Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Buffers and Standards
  4. Chromatography Standards
  5. Drug Standards
  6. 111018046

Nevirapine Related Compound B Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™

Catalog No. 111018046 Shop All MilliporeSigma Supelco Products
Change view
Click to view available options
Quantity:
50 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
11-101-8046 50 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 11-101-8046 Supplier MilliporeSigma Supelco Supplier No. PHR176150MG

Description

Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Nevirapine is found to be the first antiretroviral agent and selective non-competitive inhibitor of the reverse transcriptase, widely used for the treatment of adults and adolescents affected with human immunodeficiency viruses (HIV).
TRUSTED_SUSTAINABILITY

Specifications

CAS 287980-84-1
Purity Grade Notes These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
Linear Formula C12H10N4 O
Synonym 5,11-Dihydro-4-methyl-6 H-dipyrido[3,2-b:2′,3′-e][1,4 ]diazepin-6-one; 5,11-DIHYDRO-4-METHYL- 6 H-DIPYRIDO[3,2-b:2′,3′-e][1,4 ] DIAZEPIN-6-ONE
Type Certified Reference Material
Quantity 50 mg
Formula Weight 226.23
Grade Certified Reference Material
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.